EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hereditary alpha-tryptasemia – a potential cause of severe anaphylactic reactions and a modifier of mast cell diseases

Axel Rüfer, Gerhard Müllner, Oliver Fuchs, Wolfgang R Sperr, Gregor Hoermann

Swiss Medical Weekly · 2025

DOI: 10.57187/s.3679 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Swiss Medical Weekly, 2025. Verfasst von Axel Rüfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Centre of Excellence of the European Competence Network on Mastocytosis (ECNM), Luzerner Kantonsspital, Lucerne, and Univer…. Hauptthemen laut MEDLINE: Anaphylaxis, Tryptases, Mastocytosis. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary alpha-tryptasemia (HAT) is an autosomal dominant genetic trait affecting 4% to 6% of the general population. Hereditary alpha-tryptasemia is caused by an excess of alpha tryptase encoding TPSAB1 copy numbers on one parenteral allele, most often duplications or triplications, leading to elevated levels of basal serum tryptase. There might be a gene dosage effect between the number of additional TPSAB1 copies, the level of basal serum tryptase and the severity of clinical symptoms, including atopic, cutaneous, gastrointestinal, musculoskeletal, autonomic and neuropsychiatric manifestations. Hereditary alpha-tryptasemia is a potential risk factor for severe anaphylactic reactions. The prevalence of hereditary alpha-tryptasemia is higher in patients with systemic mastocytosis. In the diagnostic workup of patients with anaphylactic reactions and symptoms of mast cell mediator release after measurement of basal serum tryptase, it is therefore essential to screen for both the KIT D816V activating point mutation and hereditary alpha-tryptasemia by droplet digital polymerase chain reaction. Such a diagnostic approach can identify patients with hereditary alpha-tryptasemia, which may allow the avoidance of further diagnostic workup with bone marrow examination. Moreover, it can identify patients at high risk of anaphylactic reactions. So far, no targeted therapy for hereditary alpha-tryptasemia is available. Treatment for symptom control consists of H1- and H2-blockers, leukotriene antagonists and cromoglicic acid. Urticaria and anaphylaxis are especially successfully treated with the monoclonal anti-IgE-antibody omalizumab in patients with hereditary alpha-tryptasemia. H1-blockers and steroids are sufficient in emergencies. As hereditary alpha-tryptasemia is a hereditary condition, first-degree relatives with anaphylactic reactions or symptoms of mast cell mediator release should be tested for hereditary alpha-tryptasemia after measurement of basal serum tryptase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaphylaxisTryptasesMastocytosisHumansMast CellsMast Cell Activation Syndrome

Substanzen

TryptasesTPSAB1 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Centre of Excellence of the European Competence Network on Mastocytosis (ECNM), Luzerner Kantonsspital, Lucerne, and University of Lucerne, Lucerne, Switzerland.
  • Allergology and Immunology, Medbase Kriens Mattenhof, Kriens, Switzerland.
  • Department of Allergology, Centre of Excellence of ECNM, Luzerner Kantonsspital, Luzern, and University of Berne, Berne, Switzerland.
  • Division of Hematology and Hemostaseology, Department of Internal Medicine I, Centre of Excellence of ECNM, Medical University of Vienna, Vienna, Austria.
  • Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • MLL Munich Leukaemia Laboratory, Reference Centre of the ECNM, Munich, Germany.

Zitieren

APA

Rüfer, A., Müllner, G., Fuchs, O., Sperr, W. R., & Hoermann, G. (2025). Hereditary alpha-tryptasemia – a potential cause of severe anaphylactic reactions and a modifier of mast cell diseases. Swiss Medical Weekly. https://doi.org/10.57187/s.3679

Vancouver

Rüfer A, Müllner G, Fuchs O, Sperr WR, Hoermann G. Hereditary alpha-tryptasemia – a potential cause of severe anaphylactic reactions and a modifier of mast cell diseases. Swiss Medical Weekly. 2025. doi:10.57187/s.3679

BibTeX
@article{Rfer2025,
  author = {Rüfer, Axel and Müllner, Gerhard and Fuchs, Oliver and Sperr, Wolfgang R and Hoermann, Gregor},
  title = {Hereditary alpha-tryptasemia – a potential cause of severe anaphylactic reactions and a modifier of mast cell diseases},
  journal = {Swiss Medical Weekly},
  year = {2025},
  doi = {10.57187/s.3679}
}
Kostenlos starten →